(Q50047316)

English

Monophosphoryl lipid A (MPL) as an adjuvant for anti-cancer vaccines: clinical results.

scientific article published in January 2010

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

24 February 2018

http://europepmc.org/abstract/MED/20665204

title

Monophosphoryl lipid A (MPL) as an adjuvant for anti-cancer vaccines: clinical results. (English)

1 reference

stated in

Europe PubMed Central

24 February 2018

http://europepmc.org/abstract/MED/20665204

author name string

Christopher W Cluff

series ordinal

1

1 reference

stated in

Europe PubMed Central

24 February 2018

http://europepmc.org/abstract/MED/20665204

language of work or name

English

0 references

publication date

1 January 2010

1 reference

stated in

Europe PubMed Central

24 February 2018

http://europepmc.org/abstract/MED/20665204

published in

Advances in Experimental Medicine and Biology

1 reference

stated in

Europe PubMed Central

24 February 2018

http://europepmc.org/abstract/MED/20665204

volume

667

1 reference

stated in

Europe PubMed Central

24 February 2018

http://europepmc.org/abstract/MED/20665204

page(s)

111-123

1 reference

stated in

Europe PubMed Central

24 February 2018

http://europepmc.org/abstract/MED/20665204

Identifiers

DOI

10.1007/978-1-4419-1603-7_10

1 reference

stated in

Europe PubMed Central

24 February 2018

http://europepmc.org/abstract/MED/20665204

PubMed ID

20665204

1 reference

stated in

Europe PubMed Central

24 February 2018

http://europepmc.org/abstract/MED/20665204

(Q50047316)

Monophosphoryl lipid A (MPL) as an adjuvant for anti-cancer vaccines: clinical results.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)